Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma—an in vivo and in vitro study
- 673 Downloads
The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has increased over the past decades in many western countries. This trend is mainly attributed to the human papillomavirus (HPV). Cancer-related actions of immunological defense systems are being intensively researched. Human toll-like receptors (TLRs) are a family of pattern recognition receptors that participate in the immunological defense against pathogens, but their actions are also linked to cancer. The expression of TLRs in cervical epithelium alters both during the clearance of HPV infection and the HPV-induced neoplasia, but the expression of TLRs has not been studied in OPSCC. Thirty-five paraffin-embedded, formalin-fixed, squamous cell carcinoma tissue specimens were analyzed for TLRs 2, 3, 4, 5, 7, and 9 and HPV and p16 statuses. The TLR 9 expression was lower in HPV-positive tumors compared with HPV-negative tumors. TLR 7 was expressed in all cancer specimens, but elevated expression was evident in HPV and/or p16-positive tumors. The majority of p16-positive tumors did not express TLR 5, whereas its expression was stronger in p16-negative tumors. The results of in vitro analysis of five human OPSCC cell lines and one human oral tongue squamous cell carcinoma cell line agree with the in vivo trends: low levels of TLR 5 and high levels of TLR 7 in p16-positive OPSCC. Overall, TLR 7 and 9 expression patterns are demonstrated here to relate to the HPV status in vivo and TLR 5 and 7 expression patterns to the p16 status in vivo and in vitro.
KeywordsHead and neck cancer Oropharynx Carcinoma HPV p16 Toll-like receptor
We wish to thank Mrs. Elina Aspiala and Mrs. Päivi Peltokangas for technical assistance, and Prof. Tuula Salo for providing the tongue cancer cell line. We thank Orion Pharmos Foundation, the Research Foundation of Finnish Otolaryngological Association, the Academy of Finland (218021, 255551; SL), and the European Research Council (242820; SL) for funding.
Conflict of interest
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
- 28.Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis Jr JS. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343–50.CrossRefPubMedGoogle Scholar
- 34.Bussu F, Sali M, Gallus R, Vellone VG, Zannoni GF, Autorino R, et al. HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer. 2013;108:1157–62.CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque Jr R, et al. Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter. 2013;18:22–32.CrossRefPubMedGoogle Scholar
- 40.Pimentel-Nunes P, Goncalves N, Boal-Carvalho I, Afonso L, Lopes P, Roncon-Albuquerque Jr R, et al. Decreased Toll-interacting protein and peroxisome proliferator-activated receptor are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol. 2012;65:302–8.CrossRefPubMedGoogle Scholar
- 46.Cherfils-Vicini J, Damotte D, Fridman WH, Sautes-Fridman C, Cremer I. Human lung cancer: role of TLR7 and TLR8 in cell survival and chemoresistance. M S-Med Sci. 2010;26:435–7.Google Scholar